Rolph Timothy (CIK 1779479) reported 57 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-12-09). Recent activity: Sell AKRO (43,810 shares), Sell AKRO (238,339 shares), Buy AKRO (3,527 shares), Buy AKRO (43,064 shares), Buy AKRO (4,284 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-12-09 | Akero Therapeutics, Inc. (AKRO) | Chief Scientific Officer | Sell | 43,810 | $0 |
| 2025-12-09 | Akero Therapeutics, Inc. (AKRO) | Chief Scientific Officer | Sell | 238,339 | $0 |
| 2025-11-28 | Akero Therapeutics, Inc. (AKRO) | Chief Scientific Officer | Buy | 3,527 | $99,990 |
| 2025-11-28 | Akero Therapeutics, Inc. (AKRO) | Chief Scientific Officer | Buy | 43,064 | $273,887 |
| 2025-11-28 | Akero Therapeutics, Inc. (AKRO) | Chief Scientific Officer | Buy | 4,284 | $90,350 |
| 2025-11-28 | Akero Therapeutics, Inc. (AKRO) | Chief Scientific Officer | Buy | 2,796 | $1,734 |
| 2025-11-28 | Akero Therapeutics, Inc. (AKRO) | Chief Scientific Officer | Buy | 94,268 | $58,446 |
| 2025-11-28 | Akero Therapeutics, Inc. (AKRO) | Chief Scientific Officer | Buy | 4,739 | $99,993 |
| 2025-11-19 | Akero Therapeutics, Inc. (AKRO) | Chief Scientific Officer | Sell | 37,100 | $0 |
| 2025-10-09 | Akero Therapeutics, Inc. (AKRO) | Chief Scientific Officer | Buy | 12,500 | $354,375 |
| 2025-10-09 | Akero Therapeutics, Inc. (AKRO) | Chief Scientific Officer | Sell | 11,463 | $527,413 |
| 2025-10-09 | Akero Therapeutics, Inc. (AKRO) | Chief Scientific Officer | Sell | 1,037 | $48,552 |
| 2025-09-12 | Akero Therapeutics, Inc. (AKRO) | Chief Scientific Officer | Sell | 553 | $23,790 |
| 2025-09-10 | Akero Therapeutics, Inc. (AKRO) | Chief Scientific Officer | Buy | 5,161 | $32,824 |
| 2025-09-10 | Akero Therapeutics, Inc. (AKRO) | Chief Scientific Officer | Buy | 295 | $8,363 |
| 2025-09-10 | Akero Therapeutics, Inc. (AKRO) | Chief Scientific Officer | Sell | 12,466 | $550,623 |
| 2025-09-10 | Akero Therapeutics, Inc. (AKRO) | Chief Scientific Officer | Sell | 34 | $1,526 |
| 2025-09-10 | Akero Therapeutics, Inc. (AKRO) | Chief Scientific Officer | Buy | 7,044 | $148,558 |
| 2025-08-07 | Akero Therapeutics, Inc. (AKRO) | Chief Scientific Officer | Buy | 12,500 | $263,625 |
| 2025-08-07 | Akero Therapeutics, Inc. (AKRO) | Chief Scientific Officer | Sell | 5,538 | $271,750 |
| 2025-08-07 | Akero Therapeutics, Inc. (AKRO) | Chief Scientific Officer | Sell | 6,962 | $344,549 |
| 2025-07-09 | Akero Therapeutics, Inc. (AKRO) | Chief Scientific Officer | Sell | 41 | $2,157 |
| 2025-07-09 | Akero Therapeutics, Inc. (AKRO) | Chief Scientific Officer | Buy | 12,500 | $263,625 |
| 2025-07-09 | Akero Therapeutics, Inc. (AKRO) | Chief Scientific Officer | Sell | 10,634 | $541,590 |
| 2025-07-09 | Akero Therapeutics, Inc. (AKRO) | Chief Scientific Officer | Sell | 1,825 | $94,900 |
Source: SEC Form 4 filings · as of 2025-12-09